Our results were in accordance with the positive correlation observed between α6-integrin expression and its target genes ZEB1, YAP1, FGFR1, and FOXM1 in GBM from two different databases, including respectively 539 and 184 patients. This evidence concerns the gene ZEB1 and glioblastoma.